AUS
NZ
UK
CA
USA
IND
Healthcare
Opthea’s Phase 1 Clinical Trial Of OPT-302 Is A Success
October 26, 2018 11:59 AM AEDT| By Team Kalkine MediaOpthea Limited (ASX:OPT) has come into limelight with an encouraging data released from its Phase 1b dose escalation study of a key drug against diabetic macular edema (DME). As per the results from the earlier clinical trial, Opthea?s diabetes leadi...
Compumedics China JV Update
October 26, 2018 11:25 AM AEDT| By Team Kalkine MediaCompumedics Limited (ASX: CMP) shares an update regarding the contract negotiations with the Somfit technology which is China?s leading health-check organization, Meinian Onehealth Healthcare Holdings Co., Ltd. There was an announcement made in the m...
ResMed Flags 13% Revenue Growth For September 2018 Quarter
October 26, 2018 11:15 AM AEDT| By Team Kalkine MediaCalifornia-based health company ResMed Inc (ASX: RMD) has released its quarterly results for the period ended 30 September 2018. ResMed has started Fiscal 2019 with a continued strong performance, posting 13% improvement in the top line revenue growt...
1st Group Made Continuous Growth In Annualized Contract Value (ACV) Followed By Positive Q2 Outlook
October 26, 2018 11:10 AM AEDT| By Team Kalkine Media1st Group Limited (ASX: 1ST) made an announcement of its quarterly update for the quarter ended 30 September 2018. The revenue presented remains unaudited. The managing director and the Co-Founder of the company Klaus Bartusch reveals the quarter one...
Biotron’s Bosses Exercised Options To Sell Down Their Million-Dollar Stakes
October 26, 2018 11:00 AM AEDT| By Team Kalkine MediaBiotron Limited (ASX: BIT) crashed 17.5% after its bosses in-cashed their underlying options when stock was trading at its highest peak. On 25 October 2018, Managing Director Dr Michelle Miller, Chairman Michael Hoy and Director Robert Thomas exercis...
Regis Disappointed Shareholders, Close To Swipe New Pay Policies
October 26, 2018 04:57 AM AEDT| By Team Kalkine MediaRegis Healthcare?s shareholders voted in favor of election and re-election of Directors but were not convinced to adopt the new pay policies. Shareholders were too close to hit the ?strike? with 23.59% votes against the company?s remuneration report...
Paradigm Shares Mounted on ASX after announcing Strategic Partnership with Pro Players’ Elite Network.
October 25, 2018 09:00 AM AEDT| By Team Kalkine MediaOn 25 October 2018, Paradigm Biopharmaceuticals (ASX: PAR) announced that it has entered into a Heads of Agreement regarding a strategic partnership with the New York, USA, based retired professional sporting network organization, the Pro Players? El...
Blackmores Limited’s Shares Declined Despite Reporting Strong Sales And Profit Growth In Q1
October 25, 2018 02:18 AM AEDT| By Team Kalkine MediaOn 25 October 2018, Australian natural health company - Blackmores Limited (ASX: BKL) held its Annual General Meeting in which the company discussed the results of FY 2018 and also announced about the ?strong sales and profit growth in the first quar...
IHL’s Application Process On Track To Obtain License To Import, Store, Distribute And Export Of Medicinal Cannabis Products
October 24, 2018 12:56 PM AEDT| By Team Kalkine MediaImpression Healthcare Limited (ASX: IHL), the mouthguard maker has become serious about becoming a pot stock. For that reason, it has started the lengthy process of applying for local cannabis licenses. After the news regarding the Marijuana stock pe...
5 Healthcare/Biotech stocks – RAP, BIT, BD1, GTG and ADO
October 24, 2018 08:23 AM AEDT| By Team Kalkine MediaFrom a broad spectrum of local and off-shore funding bodies, Healthcare and Bio technology innovation continue to be major areas of investment. Reaching $8.67B in aggregated revenues by 2021, the Australian biotechnology industry is expected to grow...
Mesoblast Expands Partnership With Japan’s JCR Pharmaceuticals
October 24, 2018 07:25 AM AEDT| By Team Kalkine MediaDually listed on Australian Securities Exchange and Nasdaq, Mesoblast Limited (ASX: MSB) has announced the partnership extension with Japan based JCR Pharmaceuticals Co. Ltd. for the treatment of skin disease. Under the expanded license agreement, M...
MGC’s Cannabis Ingredient Product Taking Grounds Over Its Pharma Products
October 24, 2018 05:24 AM AEDT| By Team Kalkine MediaA price tag of $140 million is assigned to medical cannabis biopharma company (ASX: MCX) by the Edison Investment Research company. The per share value of the company is 66% above the existing stock price which is approximately 11cents per share. As...
BARD1’s Shares Mounted On ASX After Developing World-First Blood Test For Breast Cancer Detection
October 24, 2018 04:32 AM AEDT| By Team Kalkine MediaBreast cancer is one of the most common cancer in women and it is the second leading cause of cancer overall after lung cancer. In 2018, around 2.1 million new cases were diagnosed with breast cancer and 626,679 deaths occurred due to breast cancer....
Why Healthscope’s Share Price Is Trading Higher?
October 23, 2018 04:33 AM AEDT| By Team Kalkine MediaIt seems like things are shaping up for Healthscope Limited (ASX: HSO) which is regarded as the leader in the businesses of private hospitals within the Australian boundaries. The leading private hospital came forward and made an announcement that BG...
Recruitment For Phase 3 Trial In Renal Cancer: Telix Pharmaceuticals
October 23, 2018 04:05 AM AEDT| By Team Kalkine MediaTelix Pharmaceuticals (ASX: TLX) is currently developing a range of therapeutic products and diagnostic for renal cell carcinoma sufferers. For its zirconium imaging in renal cancer oncology phase 3 trial, it is preparing to commence recruitment for...
3 Healthcare And Biotech Stocks – LCT, SCU and AGH
October 19, 2018 11:11 AM AEDT| By Team Kalkine MediaIn the latest scientific scorecard Australia is in the top 5 global economies in the world. For the fifth consecutive year Australia?s health care and biotechnology sector continues to show healthy performance. Despite of the challenges there has bee...
PharmAust’s Stock Declines Despite Announcing Significant Progress In Monepantel Tablet Program
October 19, 2018 10:30 AM AEDT| By Team Kalkine MediaPharmAust Limited (ASX: PAA) today announced the completion of anticancer clinical trials of various monepantel (MPL) tablet prototypes. These test which were conducted on healthy Beagle dogs in collaboration with research company BRI Biopharmaceutic...
Cynata’s Preclinical Study Demonstrates Anti-Cancer Effects From Engineered Cymerus MSCs
October 19, 2018 08:42 AM AEDT| By Team Kalkine MediaClinical stage Biotechnology company Cynata Therapeutics Limited (ASX: CYP) announced the results of preclinical studies in the development of genetically engineered cell produced using the Cymerus platform to treat various cancer. Professor Khalid...
Creso Pharma Future Seems Bright After The Legalization Of Recreational Cannabis In Canada
October 18, 2018 05:58 AM AEDT| By Team Kalkine MediaCreso Pharma Ltd.(ASX: CPH) is a leader in cannabidiol (CBD) innovation and it is involved in the operations of developing medical cannabis products. Creso?s products have wide-ranging applications in both human and animal health. In July 2017, the C...
Australian Pharmaceutical Industries Limited Announced Results For FY 2018
October 18, 2018 03:08 AM AEDT| By Team Kalkine MediaThe Australian Pharmaceutical Industries Limited (ASX:API) is involved in the operations of wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies. On 18 October 2018, Australian Pharmaceutical release...
Advertise your brand on Kalkine Media